Top Losers: AVEO Pharmaceuticals (NASDAQ:AVEO), Santander Mexico Fincl Gp SAB (NYSE:BSMX), Oncothyreon Inc (NASDAQ:ONTY), Omeros Corporation (NASDAQ:OMER)

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported a fourth-quarter 2013 loss of 32 cents per share (excluding one-time expenses), narrower than the year-ago loss of 43 cents per share and the Zacks Consensus Estimate of a loss of 40 cents. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) stock performance was -6.08% in last session and finished the day at $1.70. Traded volume was 1.35million shares in the last session and … Continue reading Top Losers: AVEO Pharmaceuticals (NASDAQ:AVEO), Santander Mexico Fincl Gp SAB (NYSE:BSMX), Oncothyreon Inc (NASDAQ:ONTY), Omeros Corporation (NASDAQ:OMER)

Asset Management: Bank of New York Mellon (NYSE:BK), Blackstone Group (NYSE:BX), KKR & Co. (NYSE:KKR), Franklin Resources (NYSE:BEN)

The Bank of New York Mellon, Corporation (NYSE:BK) land with building(s), 20 E. Washington St., Nelsonville, to Michael Mark, $28,000.The Bank of New York Mellon Corporation (NYSE:BK) stock performance was -0.12% in last session and finished the day at $33.13. Traded volume was 10,727,284 million shares in the last session and the average volume of the stock remained 5.13 million shares. The beta of the … Continue reading Asset Management: Bank of New York Mellon (NYSE:BK), Blackstone Group (NYSE:BX), KKR & Co. (NYSE:KKR), Franklin Resources (NYSE:BEN)

Biotech Top Gainer: Ariad Pharmaceuticals (NASDAQ:ARIA), CEL-SCI Corporation (NYSEMKT:CVM), Synthetic Biologics (NYSEMKT:SYN), Agenus Inc. (NASDAQ:AGEN)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) on Feb. 25 reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was 8.79% in last session and finished the day at $8.17. Traded volume was 18.32 million shares in the last session and the average volume of the stock remained 16.55 million … Continue reading Biotech Top Gainer: Ariad Pharmaceuticals (NASDAQ:ARIA), CEL-SCI Corporation (NYSEMKT:CVM), Synthetic Biologics (NYSEMKT:SYN), Agenus Inc. (NASDAQ:AGEN)

FB Nasdaq FB Facebook

Diversified Electronics Losers: Plug Power Inc (NASDAQ:PLUG), Hutchinson Technology Incorporated (NASDAQ:HTCH), Deutsche Post (FRA:DPW), Microvision (NASDAQ:MVIS)

MTI Micro did get close to commercializing its Mobion fuel cell, which is powered by methanol. It was originally designed to charge and power cellphones and other personal electronic devices. But the device never had the success of Plug Power Inc (NASDAQ:PLUG), a local fuel cell company that has focused on the forklift truck market. Plug Power Inc (NASDAQ:PLUG) was originally a joint venture of … Continue reading Diversified Electronics Losers: Plug Power Inc (NASDAQ:PLUG), Hutchinson Technology Incorporated (NASDAQ:HTCH), Deutsche Post (FRA:DPW), Microvision (NASDAQ:MVIS)

Drug manufacturer Most Active: Merck & Co. (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY), Johnson & Johnson (NYSE:JNJ), Raptor Pharmaceutical (NASDAQ:RPTP)

Bristol-Myers Squibb Co (NYSE:BMY)’s ipilimumab, or Yervoy as it’s commercially known, was dubbed the skin cancer ‘wonder’ drug by the media when it was licensed for use in the UK in 2011. Bristol-Myers Squibb Co (NYSE:BMY) dropped -0.33 percent to $54.00 Friday on volume of 8.05million shares. The intra-day range of the stock was $53.88 to $54.44. Bristol-Myers Squibb Co (NYSE:BMY) has a market capitalization … Continue reading Drug manufacturer Most Active: Merck & Co. (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY), Johnson & Johnson (NYSE:JNJ), Raptor Pharmaceutical (NASDAQ:RPTP)

Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

CytRx Corporation (NASDAQ:CYTR) reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -12.76% in last session and finished the day at $4.17. Traded volume was 11,065,087 million shares in the last session and the average volume of the stock remained 3.51 … Continue reading Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)